Subscribe for 1€
Unlimited access to all advice
More than 800 stocks listed in Paris and abroad screened. To buy ? To sell ? What course objective? Our experts engage and tell you what to do.
I SUBSCRIBE FOR 1€!
Already subscribed? I connect
OSE Immuno appoints a transitional CEO, no impact according to an analyst firm
